Related Experiment Video
Updated: Oct 8, 2025

09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
19.4K
Bilateral Sensorineural Hearing Loss in the Setting of Acute Methamphetamine Overdose
Jeremy S Reich1, Harleen K Sethi1,2, Robert T Sataloff3
1Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
Ear, Nose, & Throat Journal
|December 29, 2021
Summary
Substance abuse can cause sensorineural hearing loss (SNHL). This case details acute SNHL after a methamphetamine overdose, emphasizing the need for auditory testing post-overdose.
Area of Science:
- Ototoxicology
- Neuroscience
Background:
- Substance abuse is an infrequent but recognized cause of sensorineural hearing loss (SNHL).
- Acute SNHL can manifest following drug overdoses.
Observation:
- A 28-year-old male presented with acute SNHL after a methamphetamine overdose and incidental fentanyl ingestion.
- Initial assessment revealed moderate-to-severe right ear and severe-to-profound left ear hearing loss, alongside acute kidney injury, liver failure, and lactic acidosis.
Findings:
- The patient received a two-week course of high-dose steroids.
- Subjective hearing improvement was reported post-treatment.
- This case represents one of the few recent documented instances of SNHL linked to methamphetamine use.
Implications:
- Auditory assessment is crucial following drug overdose incidents.
- Further research is needed to elucidate the mechanisms of methamphetamine-induced ototoxicity, potentially involving neurotransmitter depletion or compromised cochlear blood flow.
More Related Videos
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
785
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
785
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
372
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
372
Drugs Acting on Autonomic Ganglia: Stimulants
1.7K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.7K
Desensitization and Tachyphylaxis
2.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.4K

